Floatz logo

Capsaicin

Neuralgia

University Hospital, Clermont-FerrandSmall moleculePhase 4 / ApprovedActive
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
73/ 100
Competitive Position
73/ 100

Competitive context

48 Active assets in the Neuralgia cohort.

Asset / SponsorPhaseRating
Dexmedetomidine
Universidad Juárez Autónoma de Tabasco
Phase 4BBB
Midazolam
Minia University
Phase 4BBB
Lidocaine
Ataturk University
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Margaux M. Salas, PhD
Phase 4BBB
Marcaine
Medipol University
Phase 4BBB

View all 50 →

Same molecule, other indications

Capsaicin is also rated in:

peripheral nervous system disorderDormant
A
Indicative · Phase 3
81 / 100
View asset →
diabetic neuropathyDormant
BBB
Indicative · Phase 4
78 / 100
View asset →
herpes zosterDormant
BBB
Indicative · Phase 3
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →